Flags Raised to Question the Validity of the FDA’s Comments Regarding Transfer of a 510(k) Clearance
M. Jason Brooke, Esq.*
August 3, 2025
M. Jason Brooke calls into question the Agency’s restatement and interpretation of the CFR, surfacing additional questions that industry would like answered.